Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators.


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
07 07 2021
Historique:
pubmed: 25 6 2021
medline: 5 3 2022
entrez: 24 6 2021
Statut: ppublish

Résumé

Small-molecular Toll-like receptor 7/8 (TLR7/8) agonists hold promise as immune modulators for a variety of immune therapeutic purposes including cancer therapy or vaccination. However, due to their rapid systemic distribution causing difficult-to-control inflammatory off-target effects, their application is still problematic, in particular systemically. To address this problem, we designed and robustly fabricated pH-responsive nanogels serving as versatile immunodrug nanocarriers for safe delivery of TLR7/8-stimulating imidazoquinolines after intravenous administration. To this aim, a primary amine-reactive methacrylamide monomer bearing a pendant squaric ester amide is introduced, which is polymerized under controlled RAFT polymerization conditions. Corresponding PEG-derived squaric ester amide block copolymers self-assemble into precursor micelles in polar protic solvents. Their cores are amine-reactive and can sequentially be transformed by acid-sensitive cross-linkers, dyes, and imidazoquinolines. Remaining squaric ester amides are hydrophilized affording fully hydrophilic nanogels with profound stability in human plasma but stimuli-responsive degradation upon exposure to endolysosomal pH conditions. The immunomodulatory behavior of the imidazoquinolines alone or conjugated to the nanogels was demonstrated by macrophages

Identifiants

pubmed: 34166595
doi: 10.1021/jacs.1c03772
pmc: PMC8267846
doi:

Substances chimiques

Adjuvants, Immunologic 0
Drug Carriers 0
Esters 0
Micelles 0
Nanogels 0
Polymers 0
Toll-Like Receptor 7 0
Toll-Like Receptor 8 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9872-9883

Références

Nat Rev Drug Discov. 2021 Feb;20(2):101-124
pubmed: 33277608
Chem Soc Rev. 2014;43(20):6982-7012
pubmed: 24948004
Biomacromolecules. 2020 Jun 8;21(6):2246-2257
pubmed: 32255626
Exp Mol Pathol. 2009 Jun;86(3):215-23
pubmed: 19186176
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
J Immunol. 2009 Sep 1;183(5):3229-36
pubmed: 19667093
ACS Nano. 2012 Mar 27;6(3):2198-214
pubmed: 22381078
J Control Release. 2018 Nov 10;289:125-145
pubmed: 30223044
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8098-103
pubmed: 27382168
ACS Appl Mater Interfaces. 2021 Feb 10;13(5):6011-6022
pubmed: 33507728
Macromol Rapid Commun. 2014 Sep;35(17):1522-7
pubmed: 24979656
Oncogene. 2008 Jan 7;27(2):190-9
pubmed: 18176600
Nano Today. 2015 Feb 1;10(1):93-117
pubmed: 25893004
Science. 2013 Sep 20;341(6152):1359-65
pubmed: 23929949
Int J Pharm. 2013 Sep 15;454(1):496-511
pubmed: 23415662
Bioconjug Chem. 2018 Aug 15;29(8):2741-2754
pubmed: 29969553
Expert Opin Biol Ther. 2004 Jul;4(7):1129-38
pubmed: 15268679
Nat Biotechnol. 2020 Mar;38(3):320-332
pubmed: 31932728
Adv Mater. 2018 Nov;30(45):e1803397
pubmed: 30276880
Nat Immunol. 2015 Apr;16(4):343-53
pubmed: 25789684
J Am Chem Soc. 2018 Oct 31;140(43):14300-14307
pubmed: 30277761
Sci Rep. 2017 Apr 21;7:46426
pubmed: 28429728
Nat Rev Immunol. 2013 Jun;13(6):453-60
pubmed: 23681101
Biomacromolecules. 2019 Feb 11;20(2):854-870
pubmed: 30608149
J Clin Pharmacol. 2007 Aug;47(8):962-9
pubmed: 17660481
J Med Chem. 2010 Jun 10;53(11):4450-65
pubmed: 20481492
Adv Drug Deliv Rev. 2017 May 15;114:79-101
pubmed: 28545888
Blood. 2005 Oct 1;106(7):2424-32
pubmed: 15976181
Cancer Res. 2021 Jan 1;81(1):27-34
pubmed: 32998999
Nat Immunol. 2021 Jan;22(1):41-52
pubmed: 33139915
ACS Chem Biol. 2014 May 16;9(5):1075-85
pubmed: 24690004
J Control Release. 2017 Feb 28;248:10-23
pubmed: 27940184
Immunity. 2013 Nov 14;39(5):806-18
pubmed: 24238338
J Med Chem. 2017 Mar 9;60(5):2084-2098
pubmed: 28146629
Angew Chem Int Ed Engl. 2018 Aug 13;57(33):10760-10764
pubmed: 30043442
Bioconjug Chem. 2016 Sep 21;27(9):2007-13
pubmed: 27504746
Chem Soc Rev. 2013 Nov 7;42(21):8220-36
pubmed: 23873344
Angew Chem Int Ed Engl. 2019 Oct 21;58(43):15390-15395
pubmed: 31397948
Cancer Immunol Immunother. 2013 Apr;62(4):787-99
pubmed: 23266830
Biomaterials. 2018 Sep;178:643-651
pubmed: 29573820
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Mar-Apr;8(2):271-99
pubmed: 26314803

Auteurs

Anne Huppertsberg (A)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Leonard Kaps (L)

Institute for Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Zifu Zhong (Z)

Department of Pharmaceutics and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium.

Sascha Schmitt (S)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Judith Stickdorn (J)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Kim Deswarte (K)

Department of Internal Medicine and Pediatrics, Ghent University, VIB Center for Inflammation Research, Ghent 9052, Belgium.

Francis Combes (F)

Laboratory of Gene Therapy, Department of Nutrition, Genetics and Ethology, Ghent University, Merelbeke 9820, Belgium.

Christian Czysch (C)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Jana De Vrieze (J)

Department of Pharmaceutics and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium.

Sabah Kasmi (S)

Department of Pharmaceutics and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium.

Niklas Choteschovsky (N)

Institute for Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Adrian Klefenz (A)

Institute for Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Carolina Medina-Montano (C)

Department of Dermatology, University Medical Center of Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Pia Winterwerber (P)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Chaojian Chen (C)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Matthias Bros (M)

Department of Dermatology, University Medical Center of Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.

Stefan Lienenklaus (S)

Institute for Laboratory Animal Science and Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.

Niek N Sanders (NN)

Laboratory of Gene Therapy, Department of Nutrition, Genetics and Ethology, Ghent University, Merelbeke 9820, Belgium.

Kaloian Koynov (K)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Detlef Schuppan (D)

Institute for Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg-University Mainz, 55131 Mainz, Germany.
Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.

Bart N Lambrecht (BN)

Department of Internal Medicine and Pediatrics, Ghent University, VIB Center for Inflammation Research, Ghent 9052, Belgium.
Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam 3015, Netherlands.

Sunil A David (SA)

ViroVax, LLC, Lawrence, Kansas 66047, United States.

Bruno G De Geest (BG)

Department of Pharmaceutics and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent 9000, Belgium.

Lutz Nuhn (L)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH